Aquestive Therapeutics Inc
0.8201 - 0.86
0.618 - 2.81
Join Discuss about AQST with like-minded investors
Top Earnings Tu 8/2 Aft: $ABNB $ADC $AHT $AIZ $AMD $ANDE $APAM $AQST $AROC $ATEN $ATRC $AVID $AYX $BCOV $BFAM $BGFV $BLKB $BTN $BXC $CDLX $CGNX $CHCT $CHK $CLW $CNDT $COKE $CPSI $CRUS $CSII $CTRA $CTSO $CWH $CXW $CZR $DCP $DENN $DLHC $EA $EVH $EXAS $EXR $FLL $FMC $FNF (1/3)
146 Replies 11 👍 11 🔥
Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The company's proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly and neuroendocrine tumors. It also develops AQST-119, an oral soluble film formulation of tadalafil for the treatment of erectile dysfunction; and APL-130277, a sublingual film using apomorphine to treat parkinson's disease. Aquestive Therapeutics, Inc. was founded in 2004 and is headquartered in Warren, New Jersey.
87 Replies 11 👍 11 🔥
The pharmaceutical company Aquestive Therapeutics (AQST).
53 Replies 11 👍 6 🔥
Next Earnings Date
Next Dividend Date
Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. The Company has commercialized one internally-developed proprietary product to date, Sympazan, has a commercial proprietary product pipeline focused on the treatment of diseases of the central nervous system, or CNS, and other unmet needs, and is developing orally administered complex molecules to provide alternatives to invasively administered standard of care therapies. The Company also collaborates with other pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and has proven capabilities for drug development and commercialization.